IIM
BEAM icon

INTECH Investment Management’s Beam Therapeutics BEAM Stock Holding History

INTECH Investment Management’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$765K Sell
32,120
-5,933
-16% -$165K 0.01% 1129
2025
Q4 		$1.05M Buy
38,053
+10,228
+37% +$261K 0.01% 1106
2025
Q3 		$675K Sell
27,825
-18,380
-40% -$366K 0.01% 1406
2025
Q2 		$786K Buy
46,205
+1,530
+3% +$26.6K 0.01% 1350
2025
Q1 		$873K Buy
44,675
+15,274
+52% +$400K 0.01% 1284
2024
Q4 		$729K Buy
29,401
+8,509
+41% +$217K 0.01% 1339
2024
Q3 		$512K Buy
+20,892
New +$540K 0.01% 1219

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

INTECH Investment Management's BEAM Position: Q1 2026 in Review

INTECH Investment Management reduced its Beam Therapeutics (BEAM) stake by 16% in Q1 2026, selling an estimated $165K and leaving 32,120 shares worth $765K. The position accounts for 0.01% of the portfolio, ranked #1129.

INTECH Investment Management first reported a position in BEAM in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.05M in Q4 2025. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • INTECH Investment Management held 32,120 shares of Beam Therapeutics worth $765K as of Q1 2026.
  • INTECH Investment Management sold 5,933 Beam Therapeutics shares in Q1 2026, an estimated $165K.
  • Beam Therapeutics made up 0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1129 holding.
  • INTECH Investment Management first reported a position in Beam Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • INTECH Investment Management's Beam Therapeutics position peaked at $1.05M in Q4 2025.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.